Skip to main content
Clinical Trials/CTRI/2023/10/058818
CTRI/2023/10/058818
Not yet recruiting
Phase 4

A Randomized comparative study of the efficacy of topical methotrexate gel 1%versus topical betamethasone diproprionate lotion in the treatment of localized alopeciaareata - nil

Amrit Malik0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Amrit Malik
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amrit Malik

Eligibility Criteria

Inclusion Criteria

  • 1\. Presence of five or fewer patches of alopecia areata, involving less than 40% scalp area
  • 2\. Stable disease without the appearance of a new patch or increase in the size of the existing patch
  • for at least 15 days

Exclusion Criteria

  • 1\. Presence of atypical patterns of alopecia areata eg: ophiasis
  • 2\. Patients who have received topical or oral treatment for alopecia areata in the past 1 month
  • 3\. Patients with any other coexisting hair disorder diagnosed based on clinical history and
  • examination (viz., trichotillomania androgenetic alopecia, telogen effluvium)
  • 4\. Presence of any contraindication for topical corticosteroids (local skin infections, skin atrophy)
  • or methotrexate;
  • 5\. Pregnant and lactating women
  • 6\. Unwilling to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials